Silicon Laboratories (SLAB) just cut the ribbon on a new R&D lab at its Austin headquarters, backed in part by a $23 million Texas Semiconductor Innovation Fund grant and focused on advanced wireless chip development.
Against that backdrop, Silicon Laboratories has seen strong share price momentum over a longer stretch, with a year to date share price return of 67.01% and a 1 year total shareholder return of 64.70% that sits on top of an 81.00% total shareholder return over three years. Short term moves have been more muted around the latest close of $220.33. This suggests the new Austin R&D lab and other recent developments are being digested into an already solid long term performance profile rather than sparking a sharp rerating on their own.
Capitalize on Silicon Laboratories' momentum by scanning a curated set of IoT and chip designers through our 89 AI infrastructure stocks.Silicon Laboratories now trades only slightly below analyst targets but sits at a much deeper estimated intrinsic discount. Is that a genuine margin of safety, or a warning that the market sees real execution risk here?
Most Popular Narrative: 1.1% Undervalued
Silicon Laboratories last closed at $220.33, which sits just under the most followed fair value marker of $222.86, leaving only a slim narrative gap to explain.
Rapid expansion of smart home, healthcare, and industrial IoT deployments, including multiple large-scale customer production ramps and a deep design win pipeline, supports robust, multi-year revenue growth as the number of connected devices in these sectors accelerates.
Read the complete narrative. Read the complete narrative.
Want to see what is baked into that $222.86 figure? The narrative leans on brisk top line expansion, a sharp margin reset, and a punchy future earnings multiple. Curious which specific revenue and profit assumptions have to line up for that to hold together?
Result: Fair Value of $222.86 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the Silicon Laboratories story can break if wireless IoT becomes more of a commodity than a differentiated offering, or if larger rivals squeeze pricing and margins harder than expected.
Find out about the key risks to this Silicon Laboratories narrative.
Another View on Silicon Laboratories Valuation
There is a catch. On a simple sales multiple, Silicon Laboratories trades at a P/S of 8.6x, which is richer than both the US Semiconductor sector at 6.8x and its peer group at 4.0x. The SWS fair ratio sits at 6.0x, which raises the question of whether the narrative premium is already reflected in the valuation.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed feelings on Silicon Laboratories after all that detail. If you want a clearer stance quickly, weigh up the 2 key rewards and 1 important warning sign.
Looking for more Silicon Laboratories style ideas?
If you stop with Silicon Laboratories, you risk missing other opportunities that fit your goals. Use the screener and keep your watchlist working harder.
- Target potential mispricing by scanning a curated pool of quality companies that look cheap on fundamentals through our 31 high quality undervalued stocks.
- Strengthen your income stream by focusing on cash generating businesses with resilient payouts using the 6 dividend fortresses.
- Guard against nasty surprises by filtering for resilient businesses with healthier profiles via the 11 resilient stocks with low risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com